Zimmer Biomet Holdings, Inc. ZBH
105.87 USD -1.60 (-1.49%)
Nov 12, 2026, 1:51 PM EST
105.72 Day range 108.99
79.58 52-week range 110.15
- YTD
- +17.74%
- 1 year
- +17.59%
News
defenseworld.net Financial Contrast: Zimmer Biomet (NYSE:ZBH) and Artivion (NYSE:AORT) Zimmer Biomet (NYSE: ZBH - Get Free Report) and Artivion (NYSE: AORT - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on…
investorplace.com Best Stocks for 2027: 3 Experts Name Their Top Picks Best stocks for 2027? Louis Navellier, Eric Fry and Jonathan Rose share five stock picks and one solar ETF across three investing themes.
benzinga.com Barclays Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $115 Barclays analyst Christopher Pasquale maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $100 to $115.
prnewswire.com Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London WARSAW, Ind., Nov. 9, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will…
marketbeat.com What Zimmer Biomet (ZBH) Said on Its Q3 Earnings Call Zimmer Biomet NYSE: ZBH raised its 2026 sales growth and adjusted earnings outlook after third-quarter growth in hips, surgical specialties and technology offset continued weakness in its knee…
benzinga.com Zimmer Biomet Launches Surgeon-Guided Autonomy To Advance Intelligent Orthopedic Surgery Built on a simple principle: transfer surgeon burden, not control, Surgeon-Guided Autonomy envisions intelligent systems that translate surgeon-defined intent into action across surgical planning,…
prnewswire.com Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery New Category Will Introduce a Closed-Loop Framework: Predict. Perform. Recover.
benzinga.com UBS Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $130 UBS analyst Patrick Wood maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $120 to $130.
benzinga.com JP Morgan Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $120 JP Morgan analyst Robbie Marcus maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and raises the price target from $117 to $120.- benzinga.com Citigroup Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $117 Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and raises the price target from $99 to $117.
benzinga.com RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $125 RBC Capital analyst Kendall Au maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $110 to $125.- benzinga.com Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $107 Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $93 to $107.
zacks.com Why Zimmer Biomet (ZBH) is a Top Momentum Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.- benzinga.com Wells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $113 Wells Fargo analyst Larry Biegelsen maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $103 to $113.
benzinga.com Wayfair, Lendingtree, Bruker, Zimmer Biomet And Other Big Stocks Moving Higher On Wednesday U.S. stocks surged, led by Wayfair after strong results; Cricut, Array Technologies, Clear Secure and others also posted double-digit gains.
benzinga.com Zimmer Biomet Holdings Q3 2026 Earnings Call Transcript Zimmer Biomet Holdings (NYSE:ZBH) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…- benzinga.com Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.47-$8.59 to $8.50-$8.60 vs $8.54 Est; Narrows FY2026 Sales Guidance from $8.553B-$8.635B to $8.594B-$8.635B vs $8.597B Est Zimmer Biomet Holdings (NYSE:ZBH) raises FY2026 Adj EPS guidance from $8.47-$8.59 to $8.50-$8.60 vs $8.54 analyst estimate. Narrows FY2026 sales outlook from $8.553 billion-$8.635 billion to $8.594…
- benzinga.com Zimmer Biomet Holdings Q3 Adj. EPS $1.90 Beats $1.88 Estimate, Sales $2.063B Beat $2.040B Estimate Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.88 by 1.06 percent. This is unchanged from the same period last year.…
benzinga.com Argus Research Reiterates Buy on Zimmer Biomet Holdings, Maintains $125 Price Target Argus Research analyst David Toung reiterates Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and maintains $125 price target.- benzinga.com Zimmer Biomet Expands Its Distribution, Supply Deal With THINK Surgical To Continue Distribution Of THINK's Wireless TMINI Miniature Robotic System Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced a multi-year…
benzinga.com Michael Burry Warns Anthropic’s Valuation Could Buy 78 Profitable S&P 500 Companies: ‘Fun Game in Times Like These’ Michael Burry calls Anthropic's valuation a 'bubble,' noting it could buy 78 profitable S&P 500 companies like Domino's and Clorox.
benzinga.com Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100 Barclays analyst Christopher Pasquale initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight rating and announces Price Target of $100.
benzinga.com Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100 Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $83 to $100.- benzinga.com Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106 Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $92 to $106.
- benzinga.com RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110 RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $101 to $110.
- benzinga.com Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93 Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $91 to $93.
- benzinga.com Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $110 Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $105 to $110.
benzinga.com Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 Est; Raises FY2026 Sales Guidance from $8.437B-$8.602B to $8.553B-$8.635B vs $8.544B Est Zimmer Biomet Holdings (NYSE:ZBH) raises FY2026 Adj EPS guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 analyst estimate. Raises FY2026 sales outlook from $8.437 billion-$8.602 billion to $8.553…- benzinga.com Zimmer Biomet Holdings Q2 Adj. EPS $2.07 Beats $2.01 Estimate, Sales $2.177B Beat $2.134B Estimate Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $2.07 per share which beat the analyst consensus estimate of $2.01 by 2.99 percent. This is unchanged from the same period last year.…
benzinga.com AI Chips Power Wall Street Higher, Dow Eyes Records: Stock Market Today Tech and semis lead the S&P 500 and Nasdaq higher into quarter-end- benzinga.com Pacira BioSciences Divests Iovera To Zimmer Biomet For Up To $140M Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced the divestiture of…
benzinga.com Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...' Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that disappoint Wall Street.
benzinga.com Stock Market Today: S&P 500 Drops Amid Tech Sell-Off, Oil Climbs To $100 On Hormuz Drama Tech stocks slide as OpenAI's user growth miss reignites AI capex skepticism, while oil rallies above $99 and the Fed's two-day meeting kicks off.
benzinga.com Earnings Scheduled For April 28, 2026 
benzinga.com This Box Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday Top Wall Street analysts changed outlook on top names, downgrading ZBH, GOSS, TRI, PCG, and BOX. See what analysts think of these stocks.- benzinga.com Earnings Scheduled For February 10, 2026
benzinga.com This Illinois Tool Works Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday 
benzinga.com Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday? Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be…
benzinga.com Earnings Scheduled For November 5, 2025 - benzinga.com Earnings Scheduled For August 7, 2025
- benzinga.com Earnings Scheduled For May 5, 2025
benzinga.com ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength.
benzinga.com Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday? It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged…- benzinga.com Earnings Scheduled For February 6, 2025
- benzinga.com NeuroOne Announces Expansion Of Existing Distribution Agreement With Zimmer Biomet For Commercialization Of OneRF Ablation System; NeuroOne Will Receive An Upfront Payment Of $3M; License Provides Exclusive Commercialization Rights For U.S. Distribution And Certain OUS Markets License Provides Exclusive Commercialization Rights for US Distribution and Certain OUS MarketsAgreement expected to boost NeuroOne sales revenue and profitabilityEDEN PRAIRIE, Minn., Oct. 31, 2024…
- benzinga.com McDonald's To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
- benzinga.com Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
- benzinga.com Earnings Scheduled For February 8, 2024 Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
- benzinga.com Earnings Scheduled For November 7, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023